We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04746066
Recruitment Status : Recruiting
First Posted : February 9, 2021
Last Update Posted : May 5, 2022
Information provided by (Responsible Party):
Società Italiana Talassemie ed Emoglobinopatie

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2030
Estimated Study Completion Date : December 2030